{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-036057","form_type":"8-K","ticker":"SANA","cik":"0001770121","company_name":"Sana Biotechnology, Inc.","filed_at":"2022-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.048309+00:00","generated_at":"2026-06-22T18:59:39.465164+00:00","sec_items":["5.05"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Sana Biotechnology adopts revised Code of Business Conduct and Ethics with enhanced conflict-of-interest policies","bullets":["Board adopted amended Code on October 27, 2022, adding details on potential conflicts of interest.","Revised Code includes policies and procedures for evaluating conflicts involving Board members.","No waivers granted; full text available on company's investor relations website.","Routine governance update with no financial or operational impact."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-036057","json":"https://secwatch.observer/filing/0001564590-22-036057.json","markdown":"https://secwatch.observer/filing/0001564590-22-036057.md","text":"https://secwatch.observer/filing/0001564590-22-036057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770121/000156459022036057/0001564590-22-036057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770121/000156459022036057/sana-8k_20221027.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T18:59:39.465164+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a6aeb4e6f52889e51875c756471fa2327e8bdc0e","claim":"Sana Biotechnology, Inc.: 董事会通过了经修订和重述的商业行为和道德准则，包括有关潜在利益冲突的额外讨论。 (effective 2022-10-27).","evidence_excerpt":"On October 27, 2022, the Board of Directors (the “ Board ”) of Sana Biotechnology, Inc. (the “ Company ”) adopted the Company’s amended and restated Code of Business Conduct and Ethics (the “ Revised Code of Conduct ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770121/000156459022036057/0001564590-22-036057-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"code of ethics"},{"label":"Effective","value":"2022-10-27"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}